Treatment of bilateral nasal polyposis and chronic refractory inhalant allergic rhinitis in a chimpanzee (Pan troglodytes)

Genevieve A. Dumonceaux, Nadine Lamberski, Donald Clutter, Stephen M. Nagy, Kathy Burek, Lyndsay Phillips

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Over a 15-yr time span, a 30-yr-old female chimpanzee (Pan troglodytes) exhibited recurrent upper respiratory disease that was suspected to be allergen induced. Until 1993, symptomatic therapy with several different antibiotics and antihistamines yielded variable results. In early 1993, the chimpanzee was consistently observed to be open-mouth breathing despite medication. Nasal polyposis was diagnosed using rigid endoscopy in September 1993, and the polyps were removed by loop excision. A fluorescent allergosorbent test was performed to differentiate hypersensitivity to specific regional allergens causing chronic inhalant allergic rhinitis. Oral immunotherapy was then instituted using standard human treatment for Sacramento Valley pollens. This combination of polyp removal and immunotherapy resulted in a marked reduction of clinical signs, and continuous oral immunotherapy has controlled these signs. Hyposensitization therapy will continue for at least 2-3 yr. The chimpanzee continues to breath normally following occasional antihistamine treatment.

Original languageEnglish (US)
Pages (from-to)215-219
Number of pages5
JournalJournal of Zoo and Wildlife Medicine
Volume28
Issue number2
StatePublished - Jun 1 1997

Fingerprint

rhinitis
Pan troglodytes
Nose
immunotherapy
Immunotherapy
antihistamines
mouth
Histamine Antagonists
Polyps
allergens
Allergens
Mouth Breathing
Immunologic Desensitization
therapeutics
endoscopy
Therapeutics
Pollen
hypersensitivity
respiratory tract diseases
Endoscopy

Keywords

  • Fluorescent allergosorbent test
  • Immunotherapy
  • Pan troglodytes
  • Polyposis

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)

Cite this

Treatment of bilateral nasal polyposis and chronic refractory inhalant allergic rhinitis in a chimpanzee (Pan troglodytes). / Dumonceaux, Genevieve A.; Lamberski, Nadine; Clutter, Donald; Nagy, Stephen M.; Burek, Kathy; Phillips, Lyndsay.

In: Journal of Zoo and Wildlife Medicine, Vol. 28, No. 2, 01.06.1997, p. 215-219.

Research output: Contribution to journalArticle

Dumonceaux, Genevieve A. ; Lamberski, Nadine ; Clutter, Donald ; Nagy, Stephen M. ; Burek, Kathy ; Phillips, Lyndsay. / Treatment of bilateral nasal polyposis and chronic refractory inhalant allergic rhinitis in a chimpanzee (Pan troglodytes). In: Journal of Zoo and Wildlife Medicine. 1997 ; Vol. 28, No. 2. pp. 215-219.
@article{f5d0e50f78bc445f99ba48390101f6f0,
title = "Treatment of bilateral nasal polyposis and chronic refractory inhalant allergic rhinitis in a chimpanzee (Pan troglodytes)",
abstract = "Over a 15-yr time span, a 30-yr-old female chimpanzee (Pan troglodytes) exhibited recurrent upper respiratory disease that was suspected to be allergen induced. Until 1993, symptomatic therapy with several different antibiotics and antihistamines yielded variable results. In early 1993, the chimpanzee was consistently observed to be open-mouth breathing despite medication. Nasal polyposis was diagnosed using rigid endoscopy in September 1993, and the polyps were removed by loop excision. A fluorescent allergosorbent test was performed to differentiate hypersensitivity to specific regional allergens causing chronic inhalant allergic rhinitis. Oral immunotherapy was then instituted using standard human treatment for Sacramento Valley pollens. This combination of polyp removal and immunotherapy resulted in a marked reduction of clinical signs, and continuous oral immunotherapy has controlled these signs. Hyposensitization therapy will continue for at least 2-3 yr. The chimpanzee continues to breath normally following occasional antihistamine treatment.",
keywords = "Fluorescent allergosorbent test, Immunotherapy, Pan troglodytes, Polyposis",
author = "Dumonceaux, {Genevieve A.} and Nadine Lamberski and Donald Clutter and Nagy, {Stephen M.} and Kathy Burek and Lyndsay Phillips",
year = "1997",
month = "6",
day = "1",
language = "English (US)",
volume = "28",
pages = "215--219",
journal = "Journal of Zoo and Wildlife Medicine",
issn = "1042-7260",
publisher = "American Association of Zoo Veterinarians",
number = "2",

}

TY - JOUR

T1 - Treatment of bilateral nasal polyposis and chronic refractory inhalant allergic rhinitis in a chimpanzee (Pan troglodytes)

AU - Dumonceaux, Genevieve A.

AU - Lamberski, Nadine

AU - Clutter, Donald

AU - Nagy, Stephen M.

AU - Burek, Kathy

AU - Phillips, Lyndsay

PY - 1997/6/1

Y1 - 1997/6/1

N2 - Over a 15-yr time span, a 30-yr-old female chimpanzee (Pan troglodytes) exhibited recurrent upper respiratory disease that was suspected to be allergen induced. Until 1993, symptomatic therapy with several different antibiotics and antihistamines yielded variable results. In early 1993, the chimpanzee was consistently observed to be open-mouth breathing despite medication. Nasal polyposis was diagnosed using rigid endoscopy in September 1993, and the polyps were removed by loop excision. A fluorescent allergosorbent test was performed to differentiate hypersensitivity to specific regional allergens causing chronic inhalant allergic rhinitis. Oral immunotherapy was then instituted using standard human treatment for Sacramento Valley pollens. This combination of polyp removal and immunotherapy resulted in a marked reduction of clinical signs, and continuous oral immunotherapy has controlled these signs. Hyposensitization therapy will continue for at least 2-3 yr. The chimpanzee continues to breath normally following occasional antihistamine treatment.

AB - Over a 15-yr time span, a 30-yr-old female chimpanzee (Pan troglodytes) exhibited recurrent upper respiratory disease that was suspected to be allergen induced. Until 1993, symptomatic therapy with several different antibiotics and antihistamines yielded variable results. In early 1993, the chimpanzee was consistently observed to be open-mouth breathing despite medication. Nasal polyposis was diagnosed using rigid endoscopy in September 1993, and the polyps were removed by loop excision. A fluorescent allergosorbent test was performed to differentiate hypersensitivity to specific regional allergens causing chronic inhalant allergic rhinitis. Oral immunotherapy was then instituted using standard human treatment for Sacramento Valley pollens. This combination of polyp removal and immunotherapy resulted in a marked reduction of clinical signs, and continuous oral immunotherapy has controlled these signs. Hyposensitization therapy will continue for at least 2-3 yr. The chimpanzee continues to breath normally following occasional antihistamine treatment.

KW - Fluorescent allergosorbent test

KW - Immunotherapy

KW - Pan troglodytes

KW - Polyposis

UR - http://www.scopus.com/inward/record.url?scp=0031157762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031157762&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 215

EP - 219

JO - Journal of Zoo and Wildlife Medicine

JF - Journal of Zoo and Wildlife Medicine

SN - 1042-7260

IS - 2

ER -